Asenapine Impurity 22 | CAS 1431973-29-3 - Request Quote
Asenapine Impurity 22
| SZ CAT No: | SZ-A071034 |
| CAS No | 1431973-29-3 |
| Mol.F. | C19H19BrN2O4 |
| Mol.Wt. | 419.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Asenapine Impurity 22 is chemically 2-((3S,4S)-4-(2-Bromophenyl)-1-methylpyrrolidin-3-yl)-4-nitrophenyl acetate. Asenapine Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Asenapine Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Asenapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1431973-29-3
Purchase 1431973-29-3
Order 1431973-29-3
Enquire 1431973-29-3
price of 1431973-29-3
1431973-29-3 Supplier
1431973-29-3 Manufacturer
1431973-29-3 Exporter
buy high quality Asenapine Impurity 22
Purchase Asenapine Impurity 22
Asenapine Impurity 22 suppliers
Asenapine Impurity 22 manufacturers
Asenapine Impurity 22 price
Order Asenapine Impurity 22
Enquire Asenapine Impurity 22
Asenapine Impurity 22 cost
Asenapine Impurity 22 Supplier
Asenapine Impurity 22 Distributor
Asenapine Impurity 22 for Method Validation
Asenapine Reference Standard
Asenapine Impurity 22 for ANDA Filing
Asenapine Impurity 22 for Forced Degradation Studies
Asenapine Impurity 22 Identification Standards
Asenapine Impurity 22 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


